240 related articles for article (PubMed ID: 32797361)
1. Hierarchical cluster analysis of cytokine profiles reveals a cutaneous vasculitis-associated subgroup in dermatomyositis.
Bai J; Wu C; Zhong D; Xu D; Wang Q; Zeng X
Clin Rheumatol; 2021 Mar; 40(3):999-1008. PubMed ID: 32797361
[TBL] [Abstract][Full Text] [Related]
2. Cytokine profiles in polymyositis and dermatomyositis complicated by rapidly progressive or chronic interstitial lung disease.
Gono T; Kaneko H; Kawaguchi Y; Hanaoka M; Kataoka S; Kuwana M; Takagi K; Ichida H; Katsumata Y; Ota Y; Kawasumi H; Yamanaka H
Rheumatology (Oxford); 2014 Dec; 53(12):2196-203. PubMed ID: 24970922
[TBL] [Abstract][Full Text] [Related]
3. Circulating VEGF-A, TNF-α, CCL2, IL-6, and IFN-γ as biomarkers of cancer in cancer-associated anti-TIF1-γ antibody-positive dermatomyositis.
Li X; Huang Y; Liu Y; Yan S; Li L; Cheng L; Li H; Zhan H; Zhang F; Li Y
Clin Rheumatol; 2023 Mar; 42(3):817-830. PubMed ID: 36357631
[TBL] [Abstract][Full Text] [Related]
4. Comparison of cytokine profiles between anti-ARS antibody-positive interstitial lung diseases and those with anti-MDA-5 antibodies.
Asakawa K; Yoshizawa K; Aoki A; Kimura Y; Tanaka T; Ohashi K; Hayashi M; Kikuchi T; Sato S; Takada T
Clin Rheumatol; 2020 Jul; 39(7):2171-2178. PubMed ID: 32056068
[TBL] [Abstract][Full Text] [Related]
5. [Altered serum cytokine expression profile in systemic sclerosis and its regulatory mechanisms].
Zhu HL; DU Q; Chen WL; Zuo XX; Li QZ; Liu SJ
Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Aug; 51(4):716-722. PubMed ID: 31420628
[TBL] [Abstract][Full Text] [Related]
6. Identification of distinct cytokine/chemokine profiles in dermatomyositis with anti-transcriptional intermediary factor 1-γ antibody.
Zhao Q; Chen Y; Diao L; Zhang S; Wu D; Xue F; Xia Q; Li H; Zheng J; Cao H
Rheumatology (Oxford); 2022 May; 61(5):2176-2184. PubMed ID: 34508564
[TBL] [Abstract][Full Text] [Related]
7. Clinical and laboratory parameters predicting cancer in dermatomyositis patients with anti-TIF1γ antibodies.
Ly NTM; Ma N; Ueda-Hayakawa I; Nguyen CTH; Anada R; Okamoto H; Fujimoto M
J Dermatol Sci; 2021 Dec; 104(3):177-184. PubMed ID: 34772582
[TBL] [Abstract][Full Text] [Related]
8. Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies.
Lundberg I; Ulfgren AK; Nyberg P; Andersson U; Klareskog L
Arthritis Rheum; 1997 May; 40(5):865-74. PubMed ID: 9153548
[TBL] [Abstract][Full Text] [Related]
9. Increased serum soluble interleukin-2 receptor levels in dermatomyositis are associated with Th17/Treg immune imbalance.
Xie Y; Zhang T; Su R; Liu L; Jiang L; Xue H; Gao C; Li X; Wang C
Clin Exp Med; 2023 Nov; 23(7):3605-3617. PubMed ID: 37528249
[TBL] [Abstract][Full Text] [Related]
10. Elevated serum levels of interleukin-1 receptor antagonist in polymyositis/dermatomyositis. A biologic marker of disease activity with a possible role in the lack of acute-phase protein response.
Gabay C; Gay-Croisier F; Roux-Lombard P; Meyer O; Maineti C; Guerne PA; Vischer T; Dayer JM
Arthritis Rheum; 1994 Dec; 37(12):1744-51. PubMed ID: 7986220
[TBL] [Abstract][Full Text] [Related]
11. Cytokine levels associated with favorable clinical outcome in the CAPSID randomized trial of convalescent plasma in patients with severe COVID-19.
Körper S; Schrezenmeier EV; Rincon-Arevalo H; Grüner B; Zickler D; Weiss M; Wiesmann T; Zacharowski K; Kalbhenn J; Bentz M; Dollinger MM; Paul G; Lepper PM; Ernst L; Wulf H; Zinn S; Appl T; Jahrsdörfer B; Rojewski M; Lotfi R; Dörner T; Jungwirth B; Seifried E; Fürst D; Schrezenmeier H
Front Immunol; 2022; 13():1008438. PubMed ID: 36275695
[TBL] [Abstract][Full Text] [Related]
12. Serum profiles of pro-inflammatory and anti-inflammatory cytokines in non-hospitalized patients with mild/moderate COVID-19 infection.
Majeed AY; Zulkafli NES; Ad'hiah AH
Immunol Lett; 2023 Aug; 260():24-34. PubMed ID: 37339685
[TBL] [Abstract][Full Text] [Related]
13. A distinct multicytokine profile is associated with anti-cyclical citrullinated peptide antibodies in patients with early untreated inflammatory arthritis.
Hitchon CA; Alex P; Erdile LB; Frank MB; Dozmorov I; Tang Y; Wong K; Centola M; El-Gabalawy HS
J Rheumatol; 2004 Dec; 31(12):2336-46. PubMed ID: 15570632
[TBL] [Abstract][Full Text] [Related]
14. Dynamic Profile of CD4
Yuan D; Tie J; Xu Z; Liu G; Ge X; Wang Z; Zhang X; Gong S; Liu G; Meng Q; Lin F; Liu Z; Fan H; Zhou X
Mediators Inflamm; 2019; 2019():9483647. PubMed ID: 31011288
[TBL] [Abstract][Full Text] [Related]
15. Differences in amniotic fluid and maternal serum cytokine levels in early midtrimester women without evidence of infection.
Chow SS; Craig ME; Jones CA; Hall B; Catteau J; Lloyd AR; Rawlinson WD
Cytokine; 2008 Oct; 44(1):78-84. PubMed ID: 18703348
[TBL] [Abstract][Full Text] [Related]
16. Patterns of cytokine and chemokine expression in peripheral blood of patients with COVID-19 associated with disease severity.
Trifonova I; Ngoc K; Nikolova M; Emilova R; Todorova Y; Gladnishka T; Christova I
Int J Immunopathol Pharmacol; 2023; 37():3946320231163681. PubMed ID: 36927211
[TBL] [Abstract][Full Text] [Related]
17. Measurement of cytokines and chemokines and association with clinical severity of dermatomyositis and clinically amyopathic dermatomyositis.
Chen M; Quan C; Diao L; Xue F; Xue K; Wang B; Li X; Zhu X; Zheng J; Cao H
Br J Dermatol; 2018 Dec; 179(6):1334-1341. PubMed ID: 30101523
[TBL] [Abstract][Full Text] [Related]
18. A Risk Score Derived from the Analysis of a Cluster of 27 Serum Inflammatory Cytokines to Predict Long Term Outcome in Patients with Acute Myocardial Infarction: a Pilot Study.
Novo G; Bellia C; Fiore M; Bonomo V; Pugliesi M; Giovino M; Sasso BL; Meraviglia S; Assennato P; Novo S; Dieli F; Ciaccio M
Ann Clin Lab Sci; 2015; 45(4):382-90. PubMed ID: 26275688
[TBL] [Abstract][Full Text] [Related]
19. Circulating levels of inflammatory cytokines in patients with psoriasis vulgaris of different Chinese medicine syndromes.
Xuan ML; Lu CJ; Han L; Xiang Y
Chin J Integr Med; 2015 Feb; 21(2):108-14. PubMed ID: 25523599
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of cytokine levels using QuantiFERON-TB Gold Plus in patients with active tuberculosis.
Suzukawa M; Takeda K; Akashi S; Asari I; Kawashima M; Ohshima N; Inoue E; Sato R; Shimada M; Suzuki J; Yamane A; Tamura A; Ohta K; Tohma S; Teruya K; Nagai H
J Infect; 2020 May; 80(5):547-553. PubMed ID: 32092390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
